Suppression of MHC class II expression by human class II trans-activator constructs lacking the N-terminal domain

International Immunology

Volumn 9, Issue 10, 1997, Pages 1545-1553

  Yun, Sheng ^a   Gustafsson, Kenth ^a   Fabre, John W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Class II trans activator; MHC class II; N terminal domain

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROLINE; SERINE; THREONINE; TRANSACTIVATOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; B CELL LYMPHOMA; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; TRANSACTIVATION;

B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENE EXPRESSION; GENES, MHC CLASS II; GENETIC VECTORS; HELA CELLS; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; RNA, MESSENGER; SEQUENCE DELETION; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0030880485     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.10.1545     Document Type: Article

References (30)

1. + T cells New Biol. 4:274
2. Griscelli, C., Lisowska-Grospierre, B. and Mach, B. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic. Rev. 1:135.
3. Reith, W., Steimle, V and Mach, B. 1995. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes Immunol. Today. 16:539
4. Seidl, C., Saraiya, C., Osterweil, Z., Fu, Y. P. and Lee, J. S 1992 Genetic complexity of regulatory mutants defective for HLA class II gene expression. J. Immunol. 148:1576.
5. Steimle, V., Otten, L. A., Zufferey, M. and Mach, B. 1993 Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
6. Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B. and Mach, B. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
7. Silacci, P., Mottet, A., Steimle, V., Reith, W. and Mach, B. 1994. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180:1329.
8. Chang, C.-H., Fontes, J. D., Peterlin, M. and Flavell, R. A. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
9. Chang, C.-H. and Flavell, R. A. 1995. Class II transactivator regulates the expression multiple genes involved in antigen presentation. J. Exp. Med. 181:765.
10. Roche, P. A. 1995. HLA-DM: an in vivo facilitator of MHC class II peptide loading. Immunity 3:259
11. Kara, C. J. and Glimcher, L. H. 1993. Promoter accessibility within the environment of the MHC is affected in class II-deficient combined immunodeficiency. EMBO J. 12:187.
12. Mitchel, P. J. and Tjian, R. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding protein. Science 245:371.
13. Riley, J. L., Westerheide, S. D., Price, J. A., Brown, J. A. and Boss, J. M. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
14. Zhou, H. and Glimcher, L. H. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
15. Lloyd, A., Yancheva, N. and Wasylyk, B. 1991. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature 352:635.
16. Attardi, L. D., Von Seggern, D. and Tjian, R. 1993. Ectopic expression of wild-type or a dominant-negative mutant of transcription factor NTF-1 disrupts normal Drosophila development. Proc. Natl Acad. Sci. USA. 90:10563.
17. Kominato, Y., Galson, D., Waterman, W. R., Webb, A. C. and Auron, P. E. 1995. Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU. 1. Mol. Cell. Biol. 15:59.
18. Rothe, M., Sarma, V., Dixit, V. M. and Goeddel, D. V. 1995. TRAF2-mediated activation of NF- kappa B by TNF receptor 2 and CD40. Science 269:1424.
19. Fuggle, S. V., Errasti, P., Daar, A. S., Fabre, J. W., Ting, A. and Morris, P. J. 1983. Localisation of MHC (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules between kidneys. Transplantation 35:385
20. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F. and Zeigler, A. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other cell surface antigens - new tools for genetic analysis. Cell 14:9
21. Hart, D. N. J. and Fabre, J. W. 1981 Major histocompatibility complex antigens in rat kidney, ureter and bladder: localisation with monoclonal antibodies and demonstration of la-positive dendritic cells. Transplantation 31:318.
22. Kalderon, D., Roberts, B. L. and Richardson, W. D. 1984. A short amino acid sequence able to specify nuclear location. Cell 39:499
23. Kalderon, D., Richardson, W. D., Markham, A. F. and Smith, A. E. 1984. Sequence requirements for nuclear location of simian virus 40 large-T antigen Nature. 311:33
24. Pascal, E. and Tjian, R. 1991. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5:1646
25. Bargou, R. C., Wagener, C., Bommert, K., Arnold, W., Daniel, P. T., Mapara, M. Y., Grinstein E., Royer, H. D. and Dorken, B. 1996. Blocking the transcription factor E2F/DP by dominant negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J. Exp. Med. 183:1205
26. Dingwall, C. and Laskey, R. A. 1991. Nuclear targeting sequences - a consensus? Trends Biol. Sci. 16:478
27. Fabre, J. 1982. The rat kidney allograft model: was it all too good to be true? Transplantation. 34:223
28. Davis, T. A., Craighead, N., Williams A. J., Scadron, A., June, C. H. and Lee, K. P. 1996. Primary porcine endothelial cells express membrane-bound B7-2 (CD86) and a soluble factor that costimulates cyclosporin A-resistant and CD28-dependent human T cell proliferation. Int. Immunol. 8:1099
29. Hatano, M., Aizawa, S.-I., Soejima, T., Shigemoto, K., Taniguch, M. and Tokuhisa, T. 1989. Specific inhibition of class II MHC gene expression by anti-sense RNA. Int. Immunol. 1:260
30. Chang, C.-H., Hong, S.-C., van Ewijk, W. and Flavell, R. A. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167